Trial Profile
A Multicenter, Randomized, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Analgesic Effect of the INL-001 Bupivacaine Hydrochloride (HCl) Collagen-Matrix Implant in Children 2 to <17 Years of Age Following Open Inguinal Hernia Repair
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2024
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Adverse reactions; Registrational
- Sponsors Innocoll
- 19 Feb 2020 Planned End Date changed from 1 Dec 2018 to 31 Jan 2024.
- 19 Feb 2020 Planned primary completion date changed from 1 Dec 2018 to 31 Jan 2024.
- 22 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.